Clinical Oncology - Issue 2/2024
Editorial
Reviews
T. Urban, P. Pokorná, O. Slabý
A. A. Soror, R. Eshagh, M. R. Fahim, A. Jamshidian, G. H. Monfared
M. Švecová, K. Fiedlerová, M. Mareková, K. Dubayová
Original Articles
J. Fínek, M. Vočka, J. Bauer, E. Kubala, K. Zycháčková, M. Šedivá, M. Gharibyar, I. Kocáková, E. Čmuchařová, M. Vaňková
M. Homolová, E. Bojtárová, M. Kováčová, K. Klučková, M. Suchánková, M. Kušíková, M. Mistrík, I. Shawkatová
P. Sorokin, M. Novozhilov, D. Utkin, Z. Abduragimova, I. Dudina, A. Nikiforchin, S. Kulikova
Case Reports
I. Šimková, R. Aiglová, F. Koubek, J. Přeček, J. Látal, E. Buriánková, L. Quinn, L. Henzlová, M. Táborský, H. Švébišová, L. Tučková, B. Melichar
Reports from the literature
Various
Clinical Oncology
2024 Číslo 2
Najčítanejšie v tomto čísle
- Significance of aberrant DNA methylation for cancer diagnostics and therapy
- Carcinoid syndrome with right-sided valve involvement – a case report and review of the literature
- Feasibility of implementation of the early tumor shrinkage as a potential predictive marker to daily clinical practice in patients with RAS wild type metastatic colorectal cancer, treated with cetuximab – a non-interventional observational study
- Factors influencing overall survival and GvHD development after allogeneic hematopoietic stem cell transplantation – single centre experience